Introduction
Hemopoiesis is the result of interactions between hemopoietic stem cells (HSC)' and their supporting stroma (1) (2) (3) . The earli- 1 . Abbreviations used in this paper: ASF, asialofetuin; CFU-GM, granulocyte-macrophage progenitor; CFU-S, multipotential hemopoietic cell; D-PBS, Dulbecco's phosphate-buffered saline; GM-CSF, granulocyte-macrophage colony-stimulating factor; HSC, hemopoietic stem cell; M-CSF, macrophage-specific colony-stimulating factor.
The Journal of Clinical Investigation, Inc. Volume 83, March 1989, 904-91 1 est event in this process involves specific recognition and binding (homing) of HSC to the stroma. This concept forms the frame of reference for bone marrow transplantation where a source of HSC is introduced into the general circulation in anticipation of their selective homing to the bone marrow (4, 5) . This is in contrast to the transplantation of other organs which are placed orthotopically or heterotopically in the recipient's body and their vasculature are surgically connected.
Homing involves specific recognition of HSC and other marrow progenitor cells by stromal cells. There has been suggestive evidence that this recognition might be mediated by carbohydrate-protein interactions (6) (7) (8) . To explore the nature of this recognition mechanism at a molecular level, we synthesized a number of probes by covalently binding p-aminophenyl derivatives of various sugars to bovine serum albumin (BSA) so that their pyranose form, necessary for lectin binding, would be preserved (9) . These "neoglycoproteins" were utilized to inhibit homing of HSC and other progenitor cells, both in vivo and in vitro. We demonstrated that in both systems, the molecular basis of homing involves lectins with galactosyl and mannosyl specificities (10) (11) (12) . Using agglutination techniques, we subsequently provided evidence (13) that these lectins (homing receptors) are located on the membrane of HSC and granulocytemacrophage precursor cells (CFU-GM).
In the present work, we have used these neoglycoproteins to characterize homing receptors on the membrane of two cloned murine cell lines, one with potential for differentiating into multiple hemopoietic lineages (B6SUT), and the other with restricted potential for differentiating into granulocytemacrophage lineage (FDCP-1). For control purposes, we have also demonstrated that these receptors are absent on the surface of mature, circulating neutrophils and erythrocytes. To demonstrate that these receptors are indeed involved in the binding of these progenitor cells to the stroma, we have quantified their binding to a cloned stromal cell line D2X with and without treatment with different enzymes to remove carbohydrate moieties that could be responsible for binding of progenitor cells. While treatment with sialidase (which exposes galactosyl residues) enhanced the binding, enzymatic removal of galactosyl and mannosyl residues almost totally eliminated the binding.
Methods
Cells. Two clones of progenitor cells were used. B6SUT is an interleukin 3 (IL-3)-dependent multipotential hemopoietic cell line, cloned from the nonadherent cell population of murine long term marrow cultures. It is capable of forming mixed colonies containing erythroid cells, neutrophilic granulocytes or basophil/mast cells in semisolid medium containing erythropoietin or conditioned medium from pokeweed mitogen-stimulated spleen cells (14) (15) (16) . When infused intravenously into lethally irradiated mice, it homes to hemopoietic tissues where it proliferates and forms colonies (17) . FDCP-I is another cell line, similarly cloned from nonadherent cells of murine long-term bone marrow cultures. Its growth is dependent on the presence of IL-3 or granulocyte-macrophage colony-stimulating factor (GM-CSF), but not macrophage-specific colony-stimulating factor (M-CSF). This cell 904 Matsuoka et al.
line can form granulocyte/macrophage colonies in semisolid medium under appropriate conditions (18, 19) . None ofthese cell lines appears to contain viruses or viral genomic products.
B6SUT cells were grown in Kincade's medium supplemented with 10% five-times-concentrated WEHI-3B-conditioned medium as a source of IL-3. They were maintained at 31 'C under 7% CO2. They were fed twice weekly and maintained at a density of -106 cells/ml. FDCP-l cells were grown in RPMI 1640 medium supplemented with 10% five-times-concentrated WEHI-3B-conditioned medium, 10% fetal calf serum (Hyclone Laboratories, Sterile Systems, Inc., Logan, UT), 1% glutamine and 1% penicillin-streptomycin. They were maintained at 370C under 5% CO2. They were passed twice weekly at -I04 cells/ml. The potential of both cell lines for in vitro differentiation was confirmed independently in our laboratory.
For stromal cells, the cloned adherent stromal cell line D2X was used. This cell line has been cloned from long-term marrow cultures that were established from C3H/HeJ mice and is capable of binding marrow cells including the two progenitor cell lines mentioned above. This cell line was maintained in RPMI 1640 (Gibco, Grand Island, NY), supplemented with 10% FCS, 1% glutamine, and 1% penicillinstreptomycin (16) . The cells were maintained at 330C under 7% CO2 and were passaged once a week following brief exposure to 0.25% trypsin. All three cell lines were provided through the courtesy of Dr.
Joel Greenberger (Worcester, MA).
As negative controls, mature murine neutrophils and red blood cells were used. To obtain mature neutrophils, the marrow content of femurs and tibias from adult C57 BI/6 mice, was flushed into a tube containing phosphate-buffered saline (PBS, pH 7.4) to which 100 U/ml of heparin was added. The cells were washed twice in the same buffer by centrifugation and were subjected to gradient centrifugation on ficoll-hypaque (specific gravity 1.077). Mature neutrophils and red cells were recovered from the bottom of the tube and red cells were subsequently removed by hypotonic shock. Smears of cells were prepared and showed > 95% neutrophils. To prepare red cells, blood was obtained by cardiac puncture into heparinized syringes. Red cells were then agglutinated in 3% dextran (clinical grade) to separate them from leukocytes. Red cells were then washed thrice in PBS (pH 7.4) by centrifugation at 200 g and resuspended in the buffer. In addition circulating red cells, neutrophils and monocytes from circulating blood of human volunteers were obtained (with informed consent) and separated by similar methods. The method for preparation of purified blood monocytes has been previously described (20, 21) .
Neoglycoproteins and labeling. The method for the synthesis of neoglycoprotein probes has been established in our laboratory and described elsewhere in detail (9) . Briefly, p-aminophenyl derivatives of f3-D-galactose, a-D-mannose, a-L-fucose (all in pyranose form) were activated by thiophosgene and covalently bound to the amino groups of BSA. The ratio of sugar to protein was calculated to be about 25.
Final preparation of neoglycoproteins was made in Dulbecco's phosphate-buffered saline (D-PBS). Concentration, (measured by the method of Lowry et al. [22] ) was 3.4 mg/ml (0.05 mM), 3.2 mg/ml (0.047 mM), and 3.2 mg/ml (0.047 mM), respectively, for galactosyl (Gal-BSA), mannosyl (Man-BSA), and fucosyl (Fuc-BSA) neoglycoproteins. Carbohydrate concentration (measured by the orcinol sulfate method [23] ), was 0.34 mg/ml (1.25 mM), 0.52 mg/ml (1.92 mM), and 0.26 mg/ml (1.02 mM) respectively for the three preparations.
The (10) . In addition, they have no hemopoietic stimulatory or inhibitory activity (10) .
Neoglycoproteins were labeled with 125I by lactoperoxidase method (24 (26) and Hill (27) (28) . Cells were then washed twice with D-PBS in a microcentrifuge and the radioactivities of the supernate and the cell pellet were counted separately as surface bound and internalized, respectively.
Cell labeling and enzymatic treatment. Progenitor cells were labeled by 51Cr using standard methods (29) . Briefly, 1 gCi of5'Cr, in the form of sodium chromate, specific activity 567 mCi/mg (ICN) was reacted with 1 ml of cells (3 X 107/cells) for I h at room temperature in a conical centrifuge tube with agitation every 10 min. Unbound radioactivity was removed from the mixture by centrifugation in D-PBS five times. The final level of radioactivity achieved was 30,000 cpm/105 cells.
D2X cells were grown in 24-well plates (Linbro, Flow Labs, McLean, VA) to confluence. After reaching confluence the serumcontaining medium was replaced by 1 ml of serum-free medium containing the desired enzymes. Enzymes were prepared in 0.1 ml solutions in D-PBS and were added to the wells to achieve the desired final concentrations. The following enzymes (all from Sigma Chemical Co.) were used in the following final concentrations: neuraminidase, (Clostridium perfringens, 0.38 U/ml), ,3-galactosidase (E. coli, 45 U/ml), a-mannosidase (almonds, 0.37 U/ml), a-L-fucosidase (bovine kidney, 0.13 U/ml). Incubations were carried out sequentially in which one enzyme treatment was followed by others, as desired. 
Results
Binding ofneoglycoproteins: with approximately similar affinity and receptor number (Fig.  2 A) . Similar data were obtained with both cell lines when radiolabeled asialofetuin was used as the ligand (data not shown). Fig. 1 A also shows that no specific binding occurred when Fuc-BSA was used, indicating the absence of specific receptor for this monosaccharide. The data for specific binding of Gal-BSA to murine mature neutrophils and red blood cells are also shown in Fig. 1 A. No specific binding was detected, nor was any binding observed in human mature blood neutrophils, monocytes and red cells (data not shown). Fig. 1 figure. Binding data for FDCP-1 were similar, having two components with similar affinities and receptor numbers (Fig. 2 B) .
Since the affinities for the two components were close, the difference being slightly more than one order of magnitude, the data were subjected to Hill analysis. When all data were plotted together (Fig. 3) nents for B6SUT cells (Fig. 4 A) and 0.99 and 0.91 for FDCP-l cells (Fig. 4 B) . These coefficients, being close to unit, further confirmed that the two components were indeed separate, indicating that mannosyl receptors have two distinct components with different affinities. Specific binding of Man-BSA for mature murine neutrophils and red blood cells is also shown in Fig. 1 (30, 31) . Similar data were observed when FDCP-1 cells were used as target cells.
To explore the relationship between receptors for the two ligands, we attempted to displace, in a similar manner, bound radiolabeled Gal-BSA in the presence of different concentrations of cold Man-BSA. The results, shown in Fig. 8 B, again demonstrate a sigmoid-shaped curve of displacement. However, when radiolabeled Man-BSA was bound to the cells, and its displacement was attempted with different concentrations of cold Gal-BSA, a biphasic displacement curve was obtained (Fig. 8 B) . In the first phase, displacement began at the concentration of 1.6 X 10`O M and then reached a plateau. A second phase of displacement began at a relatively high concentration between 10-6 and 10-s M and this continued until completion. However, Gal-BSA displaced Man-BSA in a biphasic manner, consistent with the two affinity components of Man-BSA binding. 908 Matsuoka et al. Table I . Binding of FDCP-1 cells to D2X was significantly (P < 0.0 1) enhanced by treatment of stromal cells with neuraminidase which removes terminal sialyl residues and exposes more galactosyl residues that are in penultimate position. A similar trend in binding of B6SUT cells was also observed by neuraminidase treatment, but the difference was not statistically significant. In both cell lines, sequential treatment with neuraminidase and fl-galactosidase (that remove both sialyl and galactosyl residues) almost totally abolished the binding, indicating the involvement of exposed galactosyl residues in the binding. Similar abolishment ofthe binding was observed after sequential treatment with neuraminidase, f3-galactosidase, and a-mannosidase. The differences in the binding compared to control (no treatment) were highly significant (P < 0.001). By contrast, when the sequence of enzymatic treatment was reversed, so that neuraminidase treatment was used last, and consequently galactosyl and mannosyl residues of membrane glycoconjugates would still be covered by sialyl residues and would not be available to the enzymatic cleavage, no inhibition of binding was noted. Slight enhancement ofbinding that was seen could be attributed to the removal of sialyl residues, during the last part of the sequence, leading to the exposure of more penultimate galactosyl residues. Treatment with a-fucosidase had no effect on the binding.
Discussion
Our previous studies have indicated that hemopoietic progenitor cells possess membrane lectins with specificities for galactosyl and mannosyl residues ofglycoconjugates on stromal cell membrane. Molecular interactions of the lectins with specific configuration of the carbohydrate residues appear to lead to the binding (homing) of progenitor cells to stromal cells. Thus, synthetic neoglycoproteins, containing these carbohydrate residues, can inhibit reconstitution of hemopoiesis both in vivo (12) and in vitro (10, 1). Because the marrow cell population is heterogeneous, with progenitor cells occurring at low frequencies, and because no methods are available to obtain purified preparations of marrow progenitor cells for receptor studies, in the present work we used two cloned hemopoietic progenitor cells and radiolabeled synthetic neoglycoproteins to characterize these membrane lectins. Both B6SUT (pluripotent) and FDCP-l (bipotent) cells possess membrane lectins with galactosyl and mannosyl but not fucosyl specificities. The number of these receptors is a function of the number of cells used in the binding assays.
That these receptors are indeed involved in the binding (homing) of progenitor cells to stromal cells is evident by the binding assay in which radiolabeled FDCP-I and B6SUT cells are bound to the cloned stromal cell line D2X. Normally about a third of progenitor cells bind to D2X. This proportion increases when D2X membrane is treated with neuraminidase which removes sialyl residues of membrane glycoconjugates to expose penultimate galactosyl residues. On the other hand, when galactosyl and mannosyl residues are also removed enzymatically, virtually no binding is observed. Binding is not similarly affected after treatment with fucosidase. Nor is it affected when galactosidase and mannosidase are used before neuraminidase, when galactosyl and mannosyl residues are still covered by sialyl residues and are not available to enzymatic cleavage. These results indicate that galactosyl and mannosyl receptors of progenitor cells are indeed involved in the binding of these cells to the stroma. Stromal cell carbohydrate residues in these experiments serve as membrane-bound ligands, similar to soluble neoglycoproteins. To further confirm the involvement of stromal membrane glycoconjugates in binding of progenitor cells, we attempted to inhibit glycosylation in D2X by tunicamycin. However, this treatment led to reduced plating efficiency and abrogation of adherence capacity and failed to yield conclusive results.
The presence of membrane receptors on progenitor cells with defined specificities confirms our previous observation using the agglutination technique which demonstrates that both Gal-BSA and Man-BSA, but not Fuc-BSA, can selectively agglutinate CFU-S and CFU-GM from whole marrow cell populations (13) . These studies, therefore, indicate that the receptors detected in these cloned cell lines do, indeed, represent those present in hemopoietic progenitors in whole marrow cell suspensions. From a clinical point of view, these ligands may have potential that could be exploited to enrich progenitor cells from marrow cell suspensions for bone marrow transplantation. This area deserves further exploration. That these receptors selectively interact with Gal-BSA (or ASF) and Man-BSA, but not Fuc-BSA, is also consistent with our previously reported inhibition studies which indicate that fucosyl-containing neoglycoprotein does not inhibit reconstitution of hemopoiesis (10) (11) (12) .
The observation that mature circulating blood cells (murine neutrophils and red cells as well as human blood neutrophils, monocytes, and red cells) lack these binding specificities indicates that the synthesis of these homing receptors is developmentally regulated. They are present in early stages ofdevelopment. With maturation, cells may then lose these receptors allowing them to be released into the circulation. Thus, mature circulating cells do not possess receptors. The absence of mannosyl receptors on mature human monocytes has been previously reported (32, 33 (26, 27) . In the case of mannosyl receptors, the Hill coefficient of 1.72 suggests more than one and probably two receptor components. This is further confirmed when the two components are separately subjected to Hill analysis. The Hill coefficient for both components is then calculated to be around 1.0, suggesting that indeed two different components are involved in both cell lines.
In line with this interpretation are the displacement experiments, which indicate that each ligand in nonradiolabeled form can displace bound homologous radiolabeled ligand. The displacement curve gives a typical sigmoid-shaped curve as a function ofthe concentration ofcold ligand (30, 31) . Similarly, cold Man-BSA, which has two binding components, one coinciding in affinity with that of Gal-BSA, can displace radiolabeled Gal-BSA with a similar sigmoid-shaped curve. But the cold Gal-BSA, with its single affinity component, can displace radiolabeled Man-BSA in two phases. Most of the bound Man-BSA can be displaced with a concentration of 10-7 to 10-8 M cold Gal-BSA, but much higher concentrations ofcold Gal-BSA is needed to displace it completely. This doublephase displacement curve suggests that galactosyl and mannosyl receptors may be in some way interacting and possibly forming different parts of a single molecular complex. It is to be noted that, in both FDCP-I and B6SUT cells, the total number of mannosyl receptors (both high-and low-affinity components) is almost equal to the number of galactosyl receptors. This again suggests the presence of a single molecular species of receptors, interacting similarly with all galactosyl ligands, but in two different ways with mannosyl ligands. More recent evidence from our laboratory by purification of these receptors, using affinity column chromatography (to be published later), indicates that the receptor for both galactosyl and mannosyl residues indeed consists ofa single molecular species with an Mr of 110,000 kD.
It is also to be noted that the ligands used in these studies are synthetic neoglycoproteins which cannot be considered natural counterparts of membrane glycoconjugates. It is, therefore, possible that the binding characteristics of these neoglycoproteins are entirely different from those reactive glycoconjugates which may be present on hemopoietic stromal cells. The relatively low-affinity data, obtained in these studies, may also be explained on this basis. Nonetheless, the affinity for binding of progenitor cells to stromal cells is expected to be low, because the binding is transient and, upon maturation, cells must be released from stroma to enter the blood stream. In this context, high-affinity binding can potentially prevent the release of mature cells, leading to ineffective hemopoiesis. In fact, tight binding of hemopoietic cells to marrow stroma has been shown to cause ineffective hemopoiesis (34-37). It should also be noted that a similar membrane lectin, with somewhat different specificity has been described in lymphocytes and it has been demonstrated that this lectin mediates lymphocyte homing to the high endothelium of postcapillary venules (38) (39) (40) (41) . Interaction between carbohydrates and proteins, therefore, may be a more general phenomena than heretofore recognized in determining the pattern of cellular traffic in the organisms.
